Ángel Cedazo-Mı́nguez

Author

Also Known As

A CEDAZOMINGUEZ, A Cedazo-Minguez, A Cedazo-Mı́nguez, A Mínguez, A. Cedazo-Minguez, A. Cedazo‐Minguez, A. Cedazo‐Mínguez, Angel Cedazo Minguez, Angel Cedazo-Minguez, Angel Cedazo-Mínguez

149

Publications

8.5K

Citations

H-Index

117

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Stockholm University Universidad de Navarra University of Gothenburg

ÁC

About

Ángel Cedazo-Mı́nguez is an author at Karolinska Institutet specializing in medicine, alzheimer's disease, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	38	2.5K
2	Social Sciences	11	12	491
3	Natural Sciences	6	6	754
4	Health Sciences	5	5	268
5	Public Health	1	1	342

Ángel Cedazo-Mı́nguez

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy Kelly Jean Thomas Craig, Melissa K. McCoy, Jeff Blackinton, Human Molecular Genetics Dj-1 ActsMitophagyGeneticsMolecular BiologyCell Death	2010	446
Apolipoprotein E ɛ4 magnifies lifestyle risks for dementia: a population‐based study Miia Kivipelto, Suvi Rovio, Tiia Ngandu, Journal of Cellular and Molecular Medicine Metabolic SyndromePopulation‐based StudyAlzheimer's DiseaseAgingHealthy Aging	2008	342
Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1 Anna Sandebring, Kelly Jean Thomas Craig, Alexandra Beilina, PLoS ONE MitophagyMitochondrial DysfunctionMolecular BiologyCytoskeletonCellular Physiology	2009	175
Toward a Predictive Model of Alzheimer’s Disease Progression Using Capillary Electrophoresis–Mass Spectrometry Metabolomics Clara Ibáñez, Carolina Simó, Pedro J. Martín‐Álvarez, Analytical Chemistry	2012	173
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia Erika Bereczki, Paul T. Francis, David Howlett, Alzheimer s & Dementia	2016	168
Decreased levels of guanosine 3′, 5′‐monophosphate (c<scp>GMP</scp>) in cerebrospinal fluid (<scp>CSF</scp>) are associated with cognitive decline and amyloid pathology in <scp>A</scp>lzheimer's disease Ana Ugarte, Francisco J. Gil‐Bea, Carolina García, Neuropathology and Applied Neurobiology	2014	107
A new metabolomic workflow for early detection of Alzheimer's disease Clara Ibáñez, Carolina Simó, Dinesh Kumar Barupal, Journal of Chromatography A Alzheimer's DiseaseMedicineDementiaNew Metabolomic WorkflowMetabolomic Profiling	2013	96
Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons Patricia Rodriguez‐Rodriguez, Anna Matton, Paula Merino‐Serrais, Brain Neurochemical BiomarkersInsulin SignalingAlzheimer's DiseaseInsulin RetentionDegenerative Pathology	2017	94
Activity‐Regulated Cytoskeleton‐Associated Protein in Rodent Brain is Down‐Regulated by High Fat Diet <i>in vivo</i> and by 27‐Hydroxycholesterol <i>in vitro</i> Laura Mateos, Susanne Akterin, Francisco J. Gil‐Bea, Brain Pathology Rodent BrainCellular PhysiologyMetabolic SyndromeCytoskeleton‐associated ProteinAlzheimer's Disease	2008	91
Upregulation of Brain Renin Angiotensin System by 27-Hydroxycholesterol in Alzheimer's Disease Laura Mateos, Muhammad-Al-Mustafa Ismail, Francisco J. Gil‐Bea, Journal of Alzheimer s Disease HypertensionAd RiskNeurochemical BiomarkersCerebral Vascular RegulationCsf Levels	2011	89

Page 1